Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 195710 | Other Grant/Funding Number | Canadian Institutes of Health Research |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Yale University | OTHER |
| Burnet Institute | OTHER |
| Kirby Institute | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.
Using a step-wedge design, we will conduct a Type 2 hybrid implementation trial to assess the extent to which PNEP uptake is improved over 24 months of observation using the Network for the Improvement of Addiction Treatment (NIATx) implementation strategy bundle. Nine prisons were non-randomly* allocated to one of three groups, with the groups receiving the intervention (i.e., NIATx) over 24 months at staggered time intervals (every 6 months). This will be followed by an additional 12 month post-intervention period, when sustainability will be assessed.
*Originally randomized; allocation was modified due to logistical constraints
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| NIATx group 1 | Experimental | Control (month 1-6) then NIATx (month 7-30) then Maintenance (month 31-42) |
|
| NIATx group 2 | Experimental | Control (month 7-12) then NIATx (month 13-36) then Maintenance (month 37-48) |
|
| NIATx group 3 | Experimental | Control (month 13-18) then NIATx (month 19-42) then Maintenance (month 43-54) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NIATx | Behavioral | The Network for the Improvement of Addiction Treatment (NIATx) model uses a bundle of implementation tools that include expert facilitation (coaching) and quality process improvement specifically for behavioural healthcare settings to improve access and retention in treatment. |
| Measure | Description | Time Frame |
|---|---|---|
| Effectiveness | Number of participants on the PNEP | From start to end of intervention period (24 months) |
| Measure | Description | Time Frame |
|---|---|---|
| Bloodborne virus cascade of care | Number of HIV and hepatitis C virus screenings/tests, diagnoses, and treatment initiations, among the total prison population | From start to end of intervention period (24 months) |
| Enrollment in opioid agonist therapy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- None (site level intervention)
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Nadine Kronfli | Contact | 514-934-1934 | nadine.kronfli@mcgill.ca |
| Name | Affiliation | Role |
|---|---|---|
| Nadine Kronfli | Research Institute of the McGill University Health Centre | Principal Investigator |
| Frederick L. Altice | Yale University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Edmonton Institution for Women | Not yet recruiting | Edmonton | Alberta | T5S 2H9 | Canada | |
Data requests can be made to Correctional Service Canada
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006526 | Hepatitis C |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D006525 | Hepatitis, Viral, Human |
Not provided
Not provided
Hybrid type 2 stepped-wedge implementation trial. All sites will receive the intervention (NIATx); the order in which they receive the intervention was non-randomized*.
*Originally randomized; allocation was modified due to logistical constraints
Not provided
Not provided
Not provided
Not provided
|
The number of people who inject drugs who access opioid agonist therapy among the total prison population |
| From start to end of intervention period (24 months) |
| Fraser Valley Institution for Women |
| Not yet recruiting |
| Abbotsford British Columbia |
| British Columbia |
| V2S 1A1 |
| Canada |
| Mission Institution | Not yet recruiting | Mission | British Columbia | V2V 4L8 | Canada |
| Dorchester Medium | Recruiting | Dorchester | New Brunswick | E4K 2Y9 | Canada |
| Atlantic Institution | Recruiting | Smiths Crossing | New Brunswick | E9B 1T9 | Canada |
| Nova Institution for Women | Recruiting | Truro | Nova Scotia | B2N 6R8 | Canada |
| Joyceville Institution | Not yet recruiting | Kingston | Ontario | K7L 4X9 | Canada |
| Grand Valley Institution for Women | Not yet recruiting | Kitchener | Ontario | N2P 2C5 | Canada |
| Joliette Institution for Women | Not yet recruiting | Joliette | Quebec | J6E 8W1 | Canada |
| D014777 |
| Virus Diseases |
| D018178 | Flaviviridae Infections |
| D012327 | RNA Virus Infections |
| D006505 | Hepatitis |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |